1.
Gold LS, Lebwohl MG, Bhatia N, Lin T, Pillai R. Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Fixed Combination Halobetasol Propionate 0.01% And Tazarotene 0.045% (HP/TAZ) Lotion. J of Skin [Internet]. 2019Nov.9 [cited 2022Dec.1];3:S31. Available from: https://www.jofskin.org/index.php/skin/article/view/758